IGM Biosciences, Inc. (IGMS)
NASDAQ: IGMS · Real-Time Price · USD
1.160
-0.010 (-0.85%)
At close: Jun 23, 2025, 4:00 PM
1.150
-0.010 (-0.86%)
After-hours: Jun 23, 2025, 6:53 PM EDT
IGM Biosciences Stock Forecast
IGMS's stock price has decreased by -84.11% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 8 analysts that cover IGM Biosciences stock have a consensus rating of "Hold" and an average price target of $6, which forecasts a 417.24% increase in the stock price over the next year. The lowest target is $1 and the highest is $22.
Price Target: $6 (+417.24%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for IGM Biosciences stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 7 | 7 | 7 | 7 | 7 | 7 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Hold Maintains $2 → $1 | Hold | Maintains | $2 → $1 | -13.79% | Jun 11, 2025 |
| JP Morgan | JP Morgan | Sell → Hold Upgrades n/a | Sell → Hold | Upgrades | n/a | n/a | Jan 13, 2025 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades $48 → $2 | Strong Buy → Hold | Downgrades | $48 → $2 | +72.41% | Jan 10, 2025 |
| Truist Securities | Truist Securities | Hold Maintains $12 → $2 | Hold | Maintains | $12 → $2 | +72.41% | Jan 10, 2025 |
| Stifel | Stifel | Strong Buy → Hold Downgrades $27 → $2.5 | Strong Buy → Hold | Downgrades | $27 → $2.5 | +115.52% | Jan 10, 2025 |
Financial Forecast
Revenue This Year
6.28M
from 2.68M
Increased by 134.30%
Revenue Next Year
7.68M
from 6.28M
Increased by 22.37%
EPS This Year
-1.08
from -3.24
EPS Next Year
-0.69
from -1.08
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 25.2M | 25.2M | 25.2M | ||
| Avg | 6.3M | 7.7M | 15.0M | ||
| Low | n/a | n/a | 5.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 841.4% | 301.8% | 228.4% | ||
| Avg | 134.3% | 22.4% | 95.1% | ||
| Low | - | - | -31.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.09 | -0.06 | -0.04 |
| Avg | -1.08 | -0.69 | -0.99 |
| Low | -1.98 | -2.24 | -2.68 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.